Searched for
AYVAKIT AYVAKYT
Sanofi buys US biopharma group Blueprint in $9.1 billion dealSanofi is set to acquire Blueprint Medicines for $9.1 billion, strengthening its immunology portfolio with the addition of Ayvakit/Ayvakyt,...
- Load More
Sanofi buys US biopharma group Blueprint in $9.1 billion dealIran rejects US-led Gulf security summit, says Hormuz is under its command
US nuclear power regulator proposes changing rule protecting people from radiation
US Stock Market: Heavy short selling puts spotlight on SpaceX's volatile post-IPO journey
Mythos and the fight over America's most powerful AI
The surprising reason India's most expensive stocks often keep rising
HDFC Bank shares down 20% in 2026 so far. Time to buy as the governance cloud clears up?
OpenAI offers 5% stake to Trump administration: report
India's lending boom might no longer be largely bank-led
FirstCry shares in focus ahead of Rs 300 crore Swara Baby stake sale via IPO
Global Market: China Resources New Energy shares soar on Shenzhen debut after $3.6 billion IPO
Iran's unsold oil piles up at sea as buyers stay wary
At UN, India says 'a terrorist is a terrorist', rejects any justification for terror
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service